Downs Law Firm, P.C.

Laurel Maryland Estate Planning Blog

Dementia and Alzheimer's

A New Alzheimer’s Medication Wins FDA Approval

Lecanemab (sold under the brand name Leqembi) helps reduce amyloid plaques in the brain, which are hallmarks of Alzheimer’s disease. Prevention’s recent article, “All About Lecanemab, the New FDA-Approved Alzheimer’s Drug,” reports that the drug was approved in January under the FDA’s Accelerated Approval pathway. This process allows the organization to approve drugs for serious…

Read More »

Losing the Irreplacable

My Mother has been the rock in my world since I was born and was always a loving, firm presence, who delivered wisdom to me. Not always solicited. I have always known she wanted only the best for me. She was a guide, mentor, and also the dearest friend. 

Read More »
Trust Step-Up Basis

Completed Gifts to Grantor Trust Step-Up Basis

On March 30, 2023, the Internal Revenue Service issued Revenue Ruling 2023-2, which directly impacts a wide range of irrevocable trusts, including grantor retained annuity trusts, qualified personal residence trusts, insurance trusts and other intentionally defective ‘grantor trusts.’

Read More »
Search
Categories